Skip to main content
. 2023 Nov 1;10:1923–1933. doi: 10.2147/JHC.S428741

Figure 2.

Figure 2

Survival curves (A) Total cohort; (B) Neutrophil-to-lymphocyte ratio (NLR) high versus low (p=0.02); (C) Peritoneal metastasis (Peritoneal mets) yes versus no (p=0.07); (D) Lung metastasis (Lung mets) yes vs no (p=0.09).